Search…

Lates News

21/11/2025

In the afternoon, the concept of robot rebounded, with Ampri Long rising more than 10%, and shares of Weichuang Electric, Slingshot Holdings, Henggong Precision, Zhejiang Rongtai, and Changying Precision rising by more than 5%.

Latest

3 m ago

Pfizer announced that the world's first innovative drug, Trazimab (generic name: emicizumab), which requires only a fixed dose subcutaneous injection once a week, has been officially approved by the China National Medical Products Administration for the routine prevention and treatment of heavy A-type hemophilia without factor VIII inhibitors or heavy B-type hemophilia without factor IX inhibitors in children and adults aged 12 years and older who weigh 35kg, to prevent bleeding or reduce the frequency of bleeding episodes.

5 m ago

The first fixed-dose subcutaneous injection of Pfizer's non-factor innovative therapy for hemophilia, Vyondys, has been approved in China.

5 m ago

Benefiting from the rapid development of multimodal applications, Futu Holdings (03738) has launched AI music detection services.

8 m ago

Three residential land plots in Guangzhou have been listed for sale, with a total starting price of 4.271 billion yuan.

8 m ago

Minister of Education Huai Jinping conducts a survey on the study abroad service center of the Ministry of Education.

+852 - 60190728

Customer Support

Commercial Services